FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns an anticoagulant drug, which is a synthetic dipeptide Ac-Trp-Arg-Pip⋅HCl or pharmaceutically acceptable salts thereof. Group of inventions also refers to a pharmaceutical composition containing the above anticoagulant medicinal agent and auxiliary substances – microcrystalline cellulose and stearic acid and / or its pharmaceutically acceptable salt as an active substance.
EFFECT: group of inventions provides reducing the risk of uncontrolled thrombosis.
8 cl, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNTHETIC PEPTIDE DERIVATIVE EXPRESSING ANTICOAGULANT ACTIVITY | 2007 |
|
RU2377246C2 |
| MEDICINAL PRODUCT WITH ANTICOAGULANT (INHIBITOR OF FACTOR IIA), ANTITHROMBOTIC, ANTI-INFLAMMATORY ACTIVITIES AND CONTAINING 5,7-DI(THIOPHEN-2-IL)-4,5-DIHYDRO-[1,2,4]TRIAZOLO[1,5-a ]PYRIMIDINE | 2022 |
|
RU2798587C1 |
| ANTICOAGULATION DRUG | 1996 |
|
RU2146138C1 |
| AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
| HERBAL AGENT WITH INDIRECT ANTICOAGULANT, ANTIBACTERIAL AND ANTIFUNGAL ACTION | 2023 |
|
RU2814281C1 |
| ANTICOAGULANT AGENT OF INDIRECT ACTION ON BASIS OF DIUMANCAL | 2018 |
|
RU2671983C9 |
| USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
| AGENT EXHIBITING ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2014 |
|
RU2573379C1 |
| AGENT WITH ANTITHROMBOTIC ACTIVITY | 2016 |
|
RU2627435C1 |
| STANDARD DRUG PREPARATIONS AND METHODS OF TREATING THROMBOSIS BY ORAL ADMINISTRATION OF FACTOR XA INHIBITOR | 2007 |
|
RU2452484C2 |
